https://xtacytherapeutics.com/2019/11/20/redfund-capital-signs-letter-of-intent-to-acquire-sunshine-state-tea-usa-based-cbd-tea-company/2023-04-20T17:57:13+00:00https://xtacytherapeutics.com/2020/06/23/sunshine-state-tea-begins-roll-out-of-cbd-vitamin-infused-teas/2023-04-20T17:57:06+00:00https://xtacytherapeutics.com/2020/07/22/redfund-signs-swiss-client-hempfy/2023-04-20T17:56:56+00:00https://xtacytherapeutics.com/2020/07/29/redfund-joins-cannaforum-application-to-the-dutch-government/2023-06-15T05:02:12+00:00https://xtacytherapeutics.com/2020/09/30/redfund-client-cannaforum-another-step-closer-to-dutch-license/2023-06-09T19:34:07+00:00https://xtacytherapeutics.com/2020/12/30/redfund-client-sunshine-state-tea-poised-for-global-sales-with-the-receipt-of-gtin-certificate/2023-06-15T05:02:19+00:00https://xtacytherapeutics.com/2021/02/26/global-wellness-strategies-announces-acquisition-of-kaleidousa-myco-dosing-innovator/2023-04-20T17:54:01+00:00https://xtacytherapeutics.com/2021/03/04/global-wellness-strategies-unveils-first-new-product-for-kaleidousa/2023-04-20T17:53:55+00:00https://xtacytherapeutics.com/2021/04/07/global-wellness-acquires-fast-growing-mushroom-brand-kaleidomyco/2023-04-20T17:53:40+00:00https://xtacytherapeutics.com/2021/03/31/global-wellness-introduces-kaleidomycos-trifecta-powder-in-capsule/2023-04-20T17:53:47+00:00https://xtacytherapeutics.com/2021/04/14/global-wellness-announces-kaleidomyco-signing-the-wolf-of-marketing/2023-04-20T17:53:28+00:00https://xtacytherapeutics.com/2021/04/26/global-wellness-strategies-kaleidomyco-introduce-one-shot-drink-combining-functional-mushrooms-hemp-extract/2023-04-20T17:53:19+00:00https://xtacytherapeutics.com/2021/06/15/global-wellness-strategies-corporate-update/2023-04-20T17:53:14+00:00https://xtacytherapeutics.com/2021/07/19/global-wellness-strategies-and-cannvalate-au-sign-revolutionary-psychedelic-deal/2023-04-20T17:53:05+00:00https://xtacytherapeutics.com/2021/08/09/cannvalate-definitive/2023-04-20T17:53:00+00:00https://xtacytherapeutics.com/2021/09/07/global-wellness-shanti-therapeutics-fast-tracking-their-first-in-man-mdma-trials-for-pain/2023-04-20T17:52:52+00:00https://xtacytherapeutics.com/2021/10/05/global-wellness-strategies-shanti-therapeutics-updates-symbol-change-to-gws/2023-04-20T17:52:46+00:00https://xtacytherapeutics.com/2021/11/02/global-wellness-shanti-therapeutics-appoints-renowned-dr-michael-keane-to-the-team-update-on-clinical-trials/2023-04-20T17:52:21+00:00https://xtacytherapeutics.com/2021/11/05/global-wellness-meris-kott-speaks-at-debut-liftco-psychedelics-business-summit/2023-06-09T19:33:55+00:00https://xtacytherapeutics.com/2021/11/09/global-wellness-shanti-therapeutics-files-mdma-methods-patent/2023-06-09T19:33:43+00:00https://xtacytherapeutics.com/2021/11/29/global-wellness-shanti-therapeutics-submits-human-research-ethics-committee-hrec-application/2023-06-09T19:33:32+00:00https://xtacytherapeutics.com/2022/01/20/global-wellness-shanti-therapeutics-announce-psychedelic-drug-development-agreement/2023-04-20T17:51:46+00:00https://xtacytherapeutics.com/2022/02/10/global-wellness-strategies-signs-mdma-supply-agreement-with-pharmala-biotech/2023-04-20T17:51:37+00:00https://xtacytherapeutics.com/2022/02/18/global-wellness-shanti-therapeutics-boosts-team-with-international-advisors/2023-04-20T17:51:28+00:00https://xtacytherapeutics.com/2022/04/12/global-wellness-kaleidomyco-brand-introduces-first-ever-effervescent-tablets-combining-functional-mushrooms-hemp-extract/2023-04-20T17:51:20+00:00https://xtacytherapeutics.com/2022/05/09/world-renowned-dr-sud-agarwal-joins-global-wellness-strategies/2023-04-20T17:51:11+00:00https://xtacytherapeutics.com/2022/05/12/global-wellness-readies-for-first-clinical-trial/2023-04-20T17:50:55+00:00https://xtacytherapeutics.com/2022/08/02/global-wellness-signs-custom-manufacturing-agreement-with-hempsana-holdings/2023-04-20T17:50:44+00:00https://xtacytherapeutics.com/2022/08/15/global-wellness-brand-kaleidomyco-prepares-to-go-public-global-wellness-signs-as-exclusive-corporate-advisor/2023-04-20T17:46:31+00:00https://xtacytherapeutics.com/2022/10/31/global-wellness-strategies-effervescent-cannabis-products-approved-to-launch/2023-04-20T17:46:23+00:00https://xtacytherapeutics.com/2022/11/16/gws-sunshine-state-cbd-tea-products-to-launch-at-the-ontario-cannabis-store/2023-06-09T19:33:12+00:00https://xtacytherapeutics.com/2022/11/17/global-wellness-strategies-forms-pharma-subsidiary/2023-06-09T19:33:01+00:00https://xtacytherapeutics.com/2022/12/05/global-wellness-pharma-subsidiary-supports-cancer-therapeutic-company-avm-biotechnology/2023-06-09T19:32:47+00:00https://xtacytherapeutics.com/2023/01/31/global-wellness-strategies-updates-shanti-therapeutics-focused-on-mdma-psychedelic-clinical-trials/2023-04-20T17:44:10+00:00https://xtacytherapeutics.com/2023/02/06/global-wellness-strategies-is-positioned-to-be-an-mdma-and-psilocybin-leader/2023-06-15T05:02:27+00:00https://xtacytherapeutics.com/2023/03/29/global-wellness-strategies-inc-files-annual-statements-september-2022/2023-10-30T18:36:31+00:00https://xtacytherapeutics.com/2023/04/18/gws-focused-on-shanti-therapeutics-psychedelics-news-release-2023/2023-10-30T18:36:15+00:00https://xtacytherapeutics.com/2023/07/17/notice-of-annual-general-meeting-of-shareholders-to-be-held-on-august-16-2023/2023-10-30T18:35:59+00:00https://xtacytherapeutics.com/2023/07/17/voting-instruction-form-vif-annual-general-meeting-to-be-held-on-wednesday-august-16-2023/2023-10-30T18:35:38+00:00https://xtacytherapeutics.com/2023/12/05/xtacy-therapeutics-expands-mdma-platform/2023-12-06T16:47:59+00:00https://xtacytherapeutics.com/2024/01/30/xtcy-announces-a-management-cease-trade-order/2024-02-06T23:04:45+00:00https://xtacytherapeutics.com/2024/02/07/xtcy-announces-loi-with-avm-biotechnology/2024-02-07T15:47:26+00:00https://xtacytherapeutics.com/2024/02/14/xtacy-therapeutics-provides-bi-weekly-mcto-status-update/2024-02-14T02:07:16+00:00https://xtacytherapeutics.com/2024/04/16/xtcy-filing-of-annual-financial-statements-for-year-ended-september-30-2023/2024-04-16T15:40:16+00:00https://xtacytherapeutics.com/2025/01/28/pegasus-announces-effective-date-of-consolidation/2025-01-30T13:00:19+00:00https://xtacytherapeutics.com/2025/01/30/pegasus-granted-management-cease-trade-order/2025-01-30T12:58:51+00:00https://xtacytherapeutics.com/2025/02/11/pegasus-mcto-status-update/2025-02-11T20:13:59+00:00https://xtacytherapeutics.com/2025/02/27/pegasus-mercantile-inc-announces-mcto-status-update/2025-02-27T02:23:41+00:00https://xtacytherapeutics.com/2025/03/13/pegasus-mcto-status-update-2/2025-03-13T15:29:32+00:00https://xtacytherapeutics.com/2025/03/31/pegasus-mercantile-mcto-status-update/2025-03-31T16:42:42+00:00https://xtacytherapeutics.com/2025/04/14/4270/2025-04-14T21:46:20+00:00https://xtacytherapeutics.com/2025/04/18/pegasus-files-q1-interim-financials-for-quarter-ended-december-31-2024/2025-04-18T15:23:40+00:00https://xtacytherapeutics.com/2025/09/29/pegasus-mercantile-to-acquire-independent-retailers-alliance/2025-09-29T10:19:11+00:00